CM, offers strong efficacy and a favorable safety profile compared to competitors. See why I rate ALNY stock a Hold.

Intellia Therapeutics’ stock may have taken a hit in the wake of details of a grade 4 adverse event in a phase 3 trial, but ...

At St. Clair Health, a community health system in Pittsburgh, where Dr. Pray was working to build up an organized heart ...

Shares of Intellia Therapeutics Inc. (NTLA) plunged 24% on Thursday morning after the company said that a patient in one of ...

While an adverse event reported in Intellia’s gene therapy trial was a “non-concern” for analysts, it follows a handful of ...

Understanding the signs of ATTR-CM and advocating for early testing can be life-saving. Here's what you need to ...

Intellia reports a grade 4 liver enzyme elevation in a Nex-Z trial patient; no hospitalization is required, and enrollment ...

Intellia Therapeutics (NASDAQ:NTLA) shares tumbled in the premarket on Thursday after the biotech disclosed that a patient ...

Transthyretin amyloidosis (ATTR) is a condition caused by TTR protein misfolding and amyloid deposition, particularly in the ...

Despite scientific advances in cardiovascular care, people living in rural areas and other communities with long-term ...

Shares lost a quarter of their value after the company disclosed, in a regulatory filing, signs of liver stress in a study ...